Evaluation of an EZH2 inhibitor in patient-derived orthotopic xenograft models of pediatric brain tumors alone and in combination with chemo- and radiation therapies.
Lab Invest
; 102(2): 185-193, 2022 02.
Article
in En
| MEDLINE
| ID: mdl-34802040
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Brain Neoplasms
/
Xenograft Model Antitumor Assays
/
Enzyme Inhibitors
/
Enhancer of Zeste Homolog 2 Protein
Limits:
Adolescent
/
Animals
/
Child
/
Female
/
Humans
/
Infant
/
Male
Language:
En
Journal:
Lab Invest
Year:
2022
Document type:
Article
Affiliation country:
Estados Unidos
Country of publication:
Estados Unidos